INTRODUCTION
Antisense oligodeoxynucleotides have proven effective as specific inhibitors of gene expression and may provide a new generation of drugs. The concept underlying this method is that an oligonucleotide on binding to its complementary sequence inside the cell interferes with mRNA translation, RNA splicing, transcription or viral replication (for reviews on antisense DNA see 1 -4) . A limiting factor for the practical use of antisense oligonucleotides is poor uptake by cells due to their high charge density (5, 6) . This is also a problem in transfection experiments where microinjection (7), liposome (8) , calcium phosphate (9) , or virus mediated (10) transfection and electroporation methods (11) have been used to introduce DNA into cells. Recently, a cationic lipid was also shown to enhance transfection efficiency when mixed with DNA (12) .
Schemes for the cellular delivery of oligonucleotides include modification of the phosphate backbone to produce non-ionic analogs (1) (eg. methyl phosphonates (13) , amidates (14) and triesters (15) ). Covalent attachment of cell receptor ligands to otherwise unmodified DNA has been explored as a method of transport via receptor mediated endocytosis (eg. epidermal growth factor (16) , sugar lysine complexes (17) , mitochondrial signal peptide (18) ). Conjugation of an oligonucleotide to polylysine was found to increase sequence specific antiviral activity (19, 20) . A cholesterol-nucleoside conjugate was recently reported for incorporation into liposomes (21) and cholesterololigonucleotide conjugates have been studied for effectiveness as potential antisense agents, however the observed effects did not depend on the sequence of the oligomer (22) . In another report, attachment of cholesterol to oligonucleotides was shown to enhance uptake into cells (23) and attachment of an aliphatic tail to oligonucleotides has been shown to produce antisense activity (24) . In addition many other unnatural hybrids have been prepared in which DNA is linked to targeting, cleaving, or reporter groups (1, 4) .
To date there have been no reports on the preparation of phospholipid-oligonucleotide hybrids. This is despite the fact that a number of derivatives of phosphatidyl nucleosides, which are biosynthetic intermediates in lipid metabolism, have shown biological activity (25) (26) (27) (28) . Also, combinations of ether lipid analogs and DNA-interactive agents, i.e. adriamycin, 4-hydroperoxycyclophosphamide, and cisplatin have been found to enhance anti-tumor activity in an additive fashion (29) .
In this communication we report the covalent attachment of a phospholipid to oligodeoxynucleotides by solid phase synthesis. We have investigated the hybridization properties, suitability as substrates for phospholipases, cellular uptake, and antiviral activity in a VSV antisense inhibition assay of several of these novel conjugates. The antiviral assay includes a comparison between lipid-oligonucleotides and both unmodified oligonucleotide diesters and thioates.
MATERIALS AND METHODS
Solvents and reagents were obtained from Aldrich, Sigma or Burdick and Jackson. 'H NMR spectra were obtained on a Varian VXR-300S spectrometer in CDC1 3 with chemical shifts reported as ppm downfield from internal tetramethylsilane. Cell densities were determined with a Coulter Counter (Model Z F ), and radioisotope levels were measured with a Beckman Model LS 5801 scintillation counter. Oligomer homologies were screened via computer using GenBank nucleotide database (release 62, Dec., 1989) (30) .
Cell Culture and Virus L929 cells (ATCC) were grown in Dulbecco's modified essential medium (DMEM) supplemented with fetal bovine serum (10% v/v, Hyclone), HEPES (10 mM, Sigma), penicillin G (100 units/ml, Gibco), streptomycin sulfate (100 mg/ml, Gibco), and glutamine (2 mM, Gibco). Plaque purified VSV (Indiana strain) was kindly provided by Buffer Fennie and virus stock was stored at -80°C. Virus titer was determined by plaque-assay (31, 32) using L929 cells in 12-well plates (Costar).
Oligodeoxynucleotide Synthesis
Oligodeoxynucleotides for melting studies were synthesized using hydrogen phosphonate methodology (33-35) (Milligen/Biosearch 8600 DNA Synthesizer). Oligodeoxynucleotide phosphorothioates were prepared as described previously (36) . Diester oligomers and lipid-oligomers used in the VSV assay were prepared by the cyanoethyl diisopropylamino phosphoramidite procedure (1.0-10 /imole scale, Milligen 7500 DNA Synthesizer). The 5'-DMT protected oligomers were HPLC purified (8 nm Rainin C 8 Dynamax-60A, 21.4x250 mm, 8 ml/min) using a 5 to 30% acetonitrile gradient in 25 mM triethylammonium phosphate (TEAP, pH 6.8). The pooled fractions (-120 ml) were partially evaporated (to -30 ml), detritylated (pH 3, -300 fi\ 10% aq. trifluoroacetic acid, 15 min) and neutralized (cone, ammonium hydroxide, -50 /*1). After extraction (ethyl acetate, 3 X30 ml), the aqueous phase was evaporated to dryness and the residue was redissolved (0.5 M NaCl, 1.5 ml) and desalted (Sephadex G-25M, PD-10, Pharmacia, 0.75 ml fractions). The DNA-containing fractions (4-7, assayed by absorbance at 260 nm) were pooled, lyophilized to a white foam, and redissolved (2% aq. NaOAc, 1.3 ml). Oligodeoxynucleotides were precipitated (3 ml ethanol, -78°C, 15 min), pelleted and dissolved in sterile water (2-5 mM). Extinction coefficients were calculated (37) .
Preparation of l,2-di-O-hexadecyl-rac-g!ycero-3-hydrogenphosphonate (2) 1,2-di-O-hexadecyl-rac-glycerol, 1, (279 mg, 0.52 mmol, Sigma) was evaporated from pyridine twice and then was dissolved in pyridine/methylene chloride (6 ml, 1/1). A 1.25 M solution of van Boom's reagent (38) 
Synthesis of Lipid-Oligodeoxynucleotide Conjugates
Conjugates for the melting studies were coupled using the automated synthesizer. Oligomers prepared via hydrogen phosphonate chemistry (1 jtmol scale) were subjected to a final coupling cycle with 2 (15-25 mg/ml, 21-35 mM in 1/1 pyridine/acetonitrile). The products were then oxidized and deblocked normally. Conjugates for viral inhibition studies were coupled manually using oligomers prepared by phosphoramidite chemistry. The 5'-detritylated, support-bound oligomers were rinsed (acetonitrile), slurried with a solution of 2 (15-25 mg, 21 -35 /*mol in 100 /tl 1/1 pyridine/acetonitrile), and treated with a solution of pivaloyl chloride (1 ml, 100 mM in 1/1 pyridine/acetonitrile) for 5 min. After solvent removal the support was washed (pyridine/acetonitrile, acetonitrile), followed by treatment with I 2 (1 ml of a 100 mM solution in THF/triethylamine/water, 8/1/1) for 5 min. Following sequential rinses with THF/water, THF, acetonitrile, and diethyl ether, oligomers were deblocked, purified (HPLC, 5-60% acetonitrile gradient), desalted, and precipitated as described previously for the DMT-protected oligomers, except for omission of the trifluoroacetic acid deprotection and ethyl acetate extraction steps. Analysis of lipid-oligodeoxynucleotide conjugates by electrophoresis (denaturing 15% polyacrylamide gels, 7 M urea, visualization by UV shadowing) and by HPLC (detection at 254 nm) indicated >95% purity.
Enzymatic Digestion of Lipid-deoxynucleotide Conjugate
Phosphodiesterase reactions were performed on lipid-DNA (30-40 (M) in 30-40 /d of buffer (50 mM tris, pH 8, 10 mM MgCl 2 , 36°C). Snake venom phosphodiesterase (20 ng; Boehringer Mannheim GmbH) and lipid-DNA were incubated for 2 h. Incubation of bovine spleen phosphodiesterase (Sigma) with lipid-DNA was for 4 h. Reactions between lipid-DNA (30-35 jtM strands) and either phospholipase C (3.6 units; Sigma, from Bacillus cereus) or phospholipase D (5 units; Sigma, from cabbage) were conducted at 36 °C for up to 4 h in buffer (88 /tl final volume, 100 mM tris, pH 8, and 10 mM CaCl 2 ). Extent of enzymatic reactions was assessed using reverse phase HPLC as described above for the analysis of lipid-DNA.
Thermal Denaturation of Oligomer Duplexes
Thermal transitions were recorded at 260 nm using an Aviv 14DS modified Cary 14 UV-Vis spectrophotometer. The insulated cell compartment was warmed from 10°C to 85°C in 1 ° increments using a Lauda RC 6 temperature controller (Brinkmann) with equilibration for one min after attaining each temperature. Samples were heated in quartz cuvettes fitted with Teflon stoppers (Hellma, masked, 1 cm path length). All thermal denaturation solutions contained 10 mM sodium phosphate buffer (pH 7.2), 100 mM NaCl, and 1 mM EDTA. Each strand was present at 2 iiM. Oligomer mixtures were heated at 90°C for 5-10 min, cooled to room temperature, and filtered (0.45 /im type HV, Millipore) before melting. Absorbance vs. temperature data were recorded automatically using the Aviv software. The absorbance vs. temperature data were converted to fraction denatured vs. temperature (after least-square fitting of the linear portions of the upper and lower baselines). The reported T m s are the temperatures at which the fraction denatured was 0.5. Oligomer Labeling and Cellular Uptake Oligodeoxynucleotides were labeled with 5'-[a-32 P] dCTP using the Klenow fragment of DNA Polymerase I (USB). Equal amounts (2 fig) of oligomer 7 (5'-CAAAAGGCACTTCAT) and a longer template strand (5'-CAAGGATGAAGTGCCTTTTG) were mixed with labeled dCTP (2 \A, 2 /*Ci, Amersham PB. 10205) and 3'-deoxy-TTP (1 /d, 5 mM) in buffer (12 pi, 10 mM Tris, 10 mM MgCl 2 , 100 mM NaCl, 1 mM DTT, 0.1 mg/ml BSA, pH 7.4), heated (55°C, 6 min), and annealed at room temperature. After treatment with polymerase (5 units, 68°C, 20 min), labeled product containing a three base 3' extention (5'-CAAAAGGCACTTCAT*C*CdT) was purified by denaturing PAGE. Lipid conjugate 9 and phosphorothioate oligomer 8 were labeled in the same manner.
In cellular uptake experiments, unlabeled oligomer (0.4 ml, 50 /tM) in DMEM/2% NuSerum spiked with 32 P-labeled oligomer (~ 500,000 cpm) was added to subconfluent L929 cell monolayers in 24-well plates (300,000 cells/well). At intervals, cells were washed twice with PBS, and solubilized in SDS gel loading buffer (200 fd), diluted into scintillation solution (5 ml, AquasoI-2, DuPont) and counted. Cell volume (2 pL/cell) was estimated from the volume of the cell pellet (60 /tl) resulting from centrifugation of a cell suspension (7 ml, 3,700,000 cells/ml, 800 rpm, 5 min, Sorvall RT6000). (Collaborative Research). Oligomer or lipid-oligomer conjugates were added to each well and incubated (2 h, 37°C). Cells were innoculated with VSV at a multiplicity of infection of 5. After four hours the medium was aspirated, the cells washed twice with PBS, and incubated with methionine-free media (30 min). Labeling was accomplished using media (0.5 ml) containing 35 Smethionine (60 jtCi/ml, 1 h, 37°C, Amersham SJ.204). Cells were washed twice with PBS and lysed with SDS loading buffer (200 fil). 35 S-labeled proteins were separated by discontinuous SDS polyacrylamide gel electrophoresis (12%), visualized by autoradiography (Kodak XAR-2), and quantified by scanning densitometry (LKB Model 2200).
Inhibition of Viral Protein Synthesis
Total cell-associated label was measured by scintillation counting of the solubilized cells. Potential toxicity of the lipidoligomer conjugates was assessed by a comparison of cellular actin protein synthesis in the presence or absence of conjugate using uninfected cells. Relative actin synthesis was determined by 35 S-methionine incorporation as described for the VSV proteins.
RESULTS

Synthesis of Lipid-OIigodeoxynucleotide Conjugates
Covalent modification of the support-bound oligodeoxynucleotide was accomplished as shown in Fig. 1. 1,2 -di-O-hexadecyl-racglycero-3-H-phosphonate 2 was coupled to the free 5'-hydroxyl terminus of the support-bound oligomer with pivaloyl chloride. Oxidation and cleavage from the support yielded the lipidoligomer conjugate 3. Similar H-phosphonate chemistry has been recently used for the synthesis of phospholipids (39, 40) . Related lipid-nucleoside conjugates have been synthesized enzymatically, using phospholipase D (41). Lipid attachment was verified via enzymatic digestion, analytical reverse phase HPLC, and polyacrylamide gel electrophoresis. Lipid-oligomer conjugates migrated as distinct bands of lower mobility than unmodified material by denaturing PAGE.
Separation of the crude reaction mixture by reverse-phase HPLC is shown in the chromatogram in Fig. 2A . Elution of the lipid-oligomer required substantially higher concentrations of acetonitrile than the free oligomer (55% and 12% respectively). The purified material eluted as a single peak under similar conditions (Fig. 2B) . In contrast to unmodified oligodeoxynucleotides, the lipid-DNA conjugates with fewer bases eluted later on the HPLC than those with more bases, as observed previously for oligomers containing a 5'-trityl group substituted with a long alkyl chain (42, 43) .
Enzymatic Digestion of Lipid-Oligonucleotide
Lipid attachment at the 5'-end of the oligomer was confirmed by enzymatic digestion. Nearly complete hydrolysis of the DNA backbone of lipid-5'-CAGTGATGTGT was accomplished using snake venom phosphodiesterase, while bovine spleen phosphodiesterase had no effect. The lipid-oligomer molecules are phospholipid derivatives, and as such are potential substrates for phospholipases. One conjugate (Hpid-5'-CAGTGATGTGT) was screened using phospholipase C and phospholipase D, enzymes which each cleave a specific phosphate ester bond of phospholipids (reviewed in 44). In the experiments, the lipid-DNA conjugate was found to remain intact using either phospholipase C or phospholipase D under standard conditions by HPLC analysis.
Thermal Denaturation of Oligomer Duplexes
Hybridization properties of lipid-oligomers were investigated by measurement of thermal denaturation profiles of 11-mer and 15-mer duplexes containing one or two 5' lipids. The results for the 11-mer duplexes are shown in Fig. 3 . The duplexes bearing a single lipid exhibited a T m decrease relative to the corresponding unmodified duplex sequences. Thus, the 11-mer It was also found that the 15-mer bis-lipid duplex T m varied reversibly (between 53°C and 56°C), depending upon the rate of sample cooling during strand annealing. Rapid cooling yielded melting temperatures at the lower end of this 3° range; slower cooling produced higher T m s. The 15-mer duplexes containing only one lipid-oligomer strand did not show this cooling rate dependence. These results may indicate the formation of some higher order lipid structures when lipid is present at each end of the duplex which are not accessible to duplexes bearing only a single lipid.
Cellular Uptake
The influence of the lipid on cellular uptake of DNA was studied using internally labeled oligonucleotides to reduce the possibility of label release due to oligonucleotide degradation. Oligomer uptake was determined by measurement of the fraction of label ( -500,000 cpm 32 P-oligomer) contained in cell-associated material at 2,4 and 7 hours (see Fig. 4 ), and applying this fraction to total added oligomer (50 /tM, 0.4 ml). Uptake was found to plateau after four hours, and the lipid-oligomer yielded 8-10 times more cell-associated counts than either the phosphodiester or phosphorothioate oligomers. Calculation of the cell-associated concentrations of each type of compound are estimated at: lipidconjugate (200 /iM), phosphorothioate (30 /*M), and phosphodiester (20 pM). Isolation (46) and PAGE analysis of unmodified labeled phosphodiester showed less than 20% degradation after 8 h and 50% after 24 h (data not shown).
Antisense Inhibition of Viral Protein Synthesis
Vesicular stomatitis virus is a simple, well-characterized negative strand RNA virus which is purifiable, easily propogated in culture, and has a genome which codes for five proteins (47) .
The effects of antisense DNA on virus production can easily be monitored using 35 S-methionine incorporation into viral proteins (48, 49) . As depicted in Fig. 5 , lipid-oligomer 15-mers were synthesized with sequences complementary to the initiation codon regions of the N (compounds 4 and 5), NS (compound 6) and G (compound 9) protein mRNAs of VSV. Other lipid-conjugates synthesized as controls consisted of a randomized sequence (compound 14), sequences with 3-and 5-mismatches relative to 9 (compounds 12 and 13), and lipid-T 15 (compound 17). Antisense 10-mer and 20-mer lipid-oligomers (compounds 10 and 11) were also prepared. Non-lipid bearing phosphorodiester (compound 7) and phosphorothioate (compound 8) oligomers and randomized controls (compounds 15 and 16) were synthesized for comparison.
The amount of VSV M, NS, N, and G proteins is reported in Table 1 as a percentage of the respective protein synthesis in untreated cells infected with VSV. The unmodified diester 7 (complementary to VSV G protein mRNA) and diester control 15 had no effect on VSV protein synthesis (at up to 200 /*M) even though these compounds remained intact under the assay condiditions. The corresponding phosphorothioate compound, 8, showed ca. 40% inhibition at the highest concentration, although the control thioate, 16, worked almost as well.
The lipid-DNA 15-mers (4, 5, 6, 9) , targeted against the N, NS, and G protein mRNAs, each inhibited VSV protein synthesis. Each lipid-oligomer reduced production of all four viral proteins quantitated, in accord with the results of previous reports (48, 49) . The level of inhibition was of the same magnitude as that observed for methylphosphonates (49) , but lower than reported for polylysine conjugates (48 150  100  50  200  150  100  50   200  150  100  50  200  150  100  50  200  150  100  50  150  100  50  200  150  100  50  200  150  100  50  200  150  100  50  200  150  100  50  200  150  100  50  200  150  100  50 consistent with reports by Miller using methylphosphonates (49) . Decreasing the length of the strand complementary to the G protein mRNA to 10 bases (compound 10) lowered the activity of the lipid-oligomer, while an increase to 20 bases (compound 11) produced protein reductions essentially the same as the parent 15-mer (compound 9).
The series of control lipid-oligomers yielded varying results in this assay. Randomization of a complementary sequence (compound 14) or insertion of 5 mismatches (compound 13) lowered the antiviral effect, but did not eliminate it. Surprisingly, a three-mismatch sequence (compound 12) and the lipid-T 15 (compound 17) were equally as effective as the antisense 15-mers, compounds 4, 5, and 9. Screening these controls against the VSV genomic sequence by computer analysis (30) showed no sequence complementarity which would explain this unexpected potency. It is possible that compound 17 derives activity from hybridization to the poly A tail of the mRNA, although this effect was not noted with methylphosphonates (49) . The occurrence of antiviral activity attributable solely to unconjugated lipid phosphonate 2 could not be assessed due to its poor water solubility.
Cellular toxicity of lipid-DNA conjugates was examined using uninfected cells. Compounds 9 or 14 (50 /*M, 6 h, 3% reduction) and compounds 6, 9, or 12 (100 /tM, 6 h, 15% reduction) showed only slight reductions in cellular actin synthesis without regard for the sequence of the conjugate DNA. The observed antiviral effects, therefore, appear to not be caused by differential cellular toxicity of lipid-DNA compounds containing different nucleotide sequences.
DISCUSSION
In the VSV viral protein inhibition assay unmodified diester oligodeoxynucleotides showed no effect at concentrations up to 200 /JM and both antisense and control thioates showed modest inhibition. We have shown that the lack of activity for diesters is not caused by rapid degradation of the oligomers in the culture medium. On the other hand, unmodified oligodeoxynucleotide diesters with base complementarity to a portion of the mRNA have been reported to have activity in a variety of assay systems against targets such as RSV (50) , HIV (51, 52) , c-myc (53) (54) (55) , PCNA (56) , and T-cell receptors (57) . Similarly, thioates have shown antisense activity in some assay systems (58, 59) , although sequences which did not have any apparent complementarity to target mRNAs also were active (60) . Therefore, activity may depend on the cell type and assay system, and may also involve interactions of the oligomers with various other cellular targets. Recent evidence that anti-HIV activity of oligomer thioates is at least in part caused by binding to HIV reverse transcriptase (58, (60) (61) (62) ) supports this conclusion.
Lipid-oligonucleotide conjugates showed concentration dependent inhibition of viral protein synthesis, although some of the control sequences were equally as effective as the antisense sequences. These effects were not due to differential toxicity of the various lipid-DNA conjugates. The oligonucleotide sequence was clearly a factor in the inhibition of viral protein synthesis, but the protein reduction did not correspond in all cases with complementarity to a viral nucleic acid target. Neither was there a correlation between lipid-oligomer base composition (ie. G/C content) and virus inhibition. VSV uses its own RNA-dependent RNA polymerase for replication and it is conceivable that this polymerase is itself a target for oligomer action. Unexpectedly high activities of control oligomers have been observed by other laboratories in antisense viral assays (22, 60) . While the precise mechanism of action of antisense oligonucleotides is not known, it is in theory a hybridization dependent event. The present results suggest that potent oligomer sequences cannot always be predicted based upon target sequence alone and they underscore the importance of testing a variety of sequences in antisense experiments.
